Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 1,701–1,720 of 18,047 drug recalls

Drug Recall Ongoing Historical recordClass II

Amoxicillin and Clavulanate Potassium Tablets USP, Chewable 400mg/57mg, 20-count bottles, Rx only, Manufactured in Canada By: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-2272-34

by Teva Pharmaceuticals USA, Inc

Reason
Subpotent Drug
Recall initiated
June 4, 2024
Reported by FDA
June 26, 2024
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Petroleum Jelly, White Petrolatum USP, NET WT 13 OZ (368g), sold under the following brands - Rite Aid, with UPC 0-11822-51349-4; Kroger, with UPC 0-41260-35275-1; Harris Teeter, with UPC 0-72036-75051-8; CVS, with UPC 0-50428-31702-0

by Consumer Product Partners, LLC

Reason
Labeling: Label Mix up; product labeled as pure white petroleum jelly actually contains petroleum jelly with Lavendar and Chamomile
Recall initiated
May 28, 2024
Reported by FDA
June 26, 2024
Distribution
Nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore Maryland, Manufactured by: Lupin Limited, Mandideep, India NDC 68180-407-03

by Lupin Pharmaceuticals Inc.

Reason
Failed Content Uniformity Specifications
Recall initiated
May 30, 2024
Reported by FDA
June 26, 2024
Distribution
Nationwide in the US

View recall →

Drug Recall Ongoing Historical recordClass II

OSSOS-SANS Reforzado con: Glucosamina Curcuma Ortiga tablets, packaged in a 30-count bottle, DISTRIBUIDOR POR: Naturistas Especializados, Alce Blanco 180-A Fracc. Industrial, Edo. de Mexico C.P. 53370

by MexHealth LLC

Reason
Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac and methocarbamol,
Recall initiated
May 22, 2024
Reported by FDA
June 26, 2024
Distribution
US Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Little Remedies Gas Relief Drops (Simethicone/Antigas), packaged in 1 fl. oz. (30 mL) bottle with dropper, Dist by Medtech Products Inc., Tarrytown, NY 10591, NDC 63029-103-02

by Denison Pharmaceuticals, LLC

Reason
cGMP deviations: Test results confirmed aypical Burkholderia Cepacia were a result of personnel error.
Recall initiated
May 28, 2024
Reported by FDA
June 26, 2024
Distribution
Recalled units were distributed to one customer. 100% recovered (113,544 units) and controlled at Denison Pharmaceuticals.

View recall →

Drug Recall Ongoing Historical recordClass III

Eptifibatide injection 20mg/10mL (2mg/mL), 10mL Single-Dose Vial, Rx only, Mfd. In India for: AuroMedics Pharma, LLC, E. Windsor, NJ 08520, NDC 55150-219-10

by Eugia US LLC

Reason
Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.
Recall initiated
May 22, 2024
Reported by FDA
June 26, 2024
Distribution
USA nationwide.

View recall →

Drug Recall Ongoing Historical recordClass II

Dexamethasone Sodium Phosphate injection USP, 120mg per 30mL (4mg/mL), 30 mL Multiple-Dose Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520, Made in India, NDC 55150-239-30

by Eugia US LLC

Reason
Failed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec.
Recall initiated
May 23, 2024
Reported by FDA
June 26, 2024
Distribution
USA Nationwide

View recall →

Drug Recall Ongoing Historical recordClass I

Docetaxel Injection, USP, 160 mg per 16 mL (10 mg per mL), 1 x 16 mL Multi-Dose Vial, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195 (USA), Made in India. NDC 25021-254-08

by Sagent Pharmaceuticals

Reason
Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
Recall initiated
May 28, 2024
Reported by FDA
June 19, 2024
Distribution
Nationwide within the USA.

View recall →

Drug Recall Ongoing Historical recordClass I

Docetaxel Injection, USP, 80 mg per 8 mL (10 mg per mL), 1 x 8 mL Multi-Dose Vial, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195 (USA), Made in India. NDC 25021-254-08

by Sagent Pharmaceuticals

Reason
Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
Recall initiated
May 28, 2024
Reported by FDA
June 19, 2024
Distribution
Nationwide within the USA.

View recall →

Drug Recall Ongoing Historical recordClass III

Asmanex Twisthaler, mometasone furoate inhalation powder, 220 mcg per actuation, 30 Metered Doses, Rx Only, Manuf. for: Organon LLC, a subsidiary of Organon & Co. Product of Singapore. NDC 78206-0114-04

by Organon Llc

Reason
Defective Container
Recall initiated
May 28, 2024
Reported by FDA
June 19, 2024
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass III

Asmanex Twisthaler, mometasone furoate inhalation powder, 220 mcg per actuation, 14 Metered Doses, Rx Only, Manuf. for: Organon LLC, a subsidiary of Organon & Co. Product of Singapore. NDC 78206-114-03

by Organon Llc

Reason
Defective Container
Recall initiated
May 28, 2024
Reported by FDA
June 19, 2024
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing Historical recordClass III

Asmanex Twisthaler, mometasone furoate inhalation powder, 220 mcg per actuation, 60 Metered Doses, Rx Only, Manuf. for: Organon LLC, a subsidiary of Organon & Co. Product of Singapore. NDC 78206-114-02

by Organon Llc

Reason
Defective Container
Recall initiated
May 28, 2024
Reported by FDA
June 19, 2024
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Phenazopyridine HCl, 100mg tablets, 6 count bottles, Rx Only, Repackaged by: RemedyRepack, Inc., Indiana, PA NDC#: 70518-0218-00, Source NDC: 75826-0114-10 MFG: Winder Laboratories, LLC, Winder, GA

by RemedyRePack Inc.

Reason
Product Mix Up. A bottle labeled as Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.
Recall initiated
May 31, 2024
Reported by FDA
June 19, 2024
Distribution
Product was distributed to one medical facility.

View recall →

Drug Recall Ongoing Historical recordClass II

Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension, 1%, 0.5%, 0.075%, 5mL, Quantity: 20mL, Rx Only, Compounded by: Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ NDC 71384-310-05

by Imprimis NJOF, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
May 14, 2024
Reported by FDA
June 19, 2024
Distribution
US Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Klarity-C (cyclosporine) Preservative-Free Sterile Ophthalmic Emulsion 0.1% 5.5mL, Rx Only, This is a compounded drug. NOT FOR RESALE. OFFICE USE ONLY Compounded by: Imprimis NJOF, LLC., 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852 NDC: 71384-514-05

by Imprimis NJOF, LLC

Reason
Lack of Assurance of Sterility
Recall initiated
May 14, 2024
Reported by FDA
June 19, 2024
Distribution
US Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-001-01. Diluent Vial Label: Diluent, 5mL, Sterile single use, Rx only, Manufactured for Pacira Pharmaceuticals Inc., NDC 65250-002-01. Carton Label: Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-003-01.

by PACIRA PHARMACEUTICALS INC

Reason
Failed Stability Specifications - at 12 months 2-8 degrees C followed by 6 weeks at 25 degrees C.
Recall initiated
May 7, 2024
Reported by FDA
June 19, 2024
Distribution
U.S. Nationwide.

View recall →

Drug Recall Completed Historical recordClass II

Phenazopyridine HCl Tablets USP, 100 mg, 100-count bottles, Rx Only, Manufactured by: Winder Laboratories, LLC. 716 Patrick Industrial Lane, Winder, GA 30680, NDC 75826-114-10,

by Winder Laboratories, LLC

Reason
Product Mix Up. A bottle of Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.
Recall initiated
May 28, 2024
Reported by FDA
June 19, 2024
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass III

Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Each carton contains one bottle of 60 tablets, one 30-mL dosing cup and one 10-mL oral dosing syringe, Rx Only, Mfd for: ViiV Healthcare Durham, NC, 27701, By: GlaxoSmithKline Durham, NC 27701, NDC 49702-255-37

by GlaxoSmithKline LLC

Reason
Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet bottle label, is 2025-APR.
Recall initiated
May 17, 2024
Reported by FDA
June 12, 2024
Distribution
Nationwide within the United States

View recall →

Drug Recall Ongoing Historical recordClass III

Estradiol Transdermal System, USP (Twice-Weekly) 0.025mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1191-8

by Zydus Pharmaceuticals (USA) Inc

Reason
Failed Impurities/Degradation Specifications.
Recall initiated
May 16, 2024
Reported by FDA
June 12, 2024
Distribution
Nationwide within the United States

View recall →

Drug Recall Ongoing Historical recordClass III

Estradiol Transdermal System, USP (Twice-Weekly) 0.0375mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1192-8

by Zydus Pharmaceuticals (USA) Inc

Reason
Failed Impurities/Degradation Specifications.
Recall initiated
May 16, 2024
Reported by FDA
June 12, 2024
Distribution
Nationwide within the United States

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.